跳至主要内容
临床试验/ISRCTN45191339
ISRCTN45191339进行中(未招募)未知

IMIT P Ca – inviting men for prostate cancer screening using luminal index, bi-parametric and PSA density, to identify men with suspicious lesions and to evaluate acceptability

niversity College London0 个研究点目标入组 800 人开始时间: 2023年3月10日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Men aged 50-75 years
  • 2. No prior prostate cancer diagnosis/treatment
  • 3. Willing and able to provide a written informed consent

排除标准

  • 1. Previous diagnosis of prostate cancer
  • 2. Contraindication to MRI scan (contraindication for MRI scanning [as assessed by the MRI safety questionnaire of the PET/MRI department] which includes but is not limited to: intracranial aneurysm clips or other metallic objects; intra-orbital metal fragments that have not been removed; pacemakers or other implanted cardiac rhythm management devices and non-MRI compatible heart valves; inner ear implants; and history of claustrophobia)
  • 3. Men who require assisted living e.g. care home living
  • 4. Lacks the capacity to consent

研究者

发起方
niversity College London

相似试验